1 Artiva Biotherapeutics Inc Receivables Turnover Ratio (ARTV), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Artiva Biotherapeutics Inc   (NASDAQ: ARTV)
 

Artiva Biotherapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Artiva Biotherapeutics Inc 's ability to collect accounts receivable sequentially worsen to 13.62, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Artiva Biotherapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 27 days, from 16 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Artiva Biotherapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Artiva Biotherapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARTV Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 370 % - -54.11 % -88.73 % -97.95 %
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) 13.62 22.2 9.53 - -
ARTV's Total Ranking # # # # #
Accounts Receivable average collection period days 27 16 38 - -
Seq. Receivable Change - - -15.19 % 163.33 % -87.18 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





ARTV Company Profile • Back to ARTV Efficiency Comparisons • Compare ARTV Receivables Turnover Ratio to its Competitors

Financial Statements
Artiva Biotherapeutics Inc 's Accounts Receivable $ 0 Millions Visit ARTV's Balance sheet
Artiva Biotherapeutics Inc 's Sales TTM $ 1 Millions Visit ARTV's Income Statement
Sources of ARTV's Revenues Visit ARTV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARTV's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARTV's Growth Rates ARTV's Roa ARTV's Inventory Turnover Ratio ARTV's Dividend Comparisons
ARTV's Profitability Ratios ARTV's Roi ARTV's Asset Turnover Ratio ARTV's Dividend Growth
ARTV's Valuation Ratios ARTV's Roe ARTV's Financial Strength Ratios ARTV's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Neuraxis Inc   18.95 $ 5.316  Millions$ 0.281  Millions
China Pharma Holdings Inc  18.55 $ 3.914  Millions$ 0.211  Millions
Bausch Health Companies Inc   18.42 $ 10,853.000  Millions$ 589.250  Millions
Arvinas Inc   17.26 $ 316.700  Millions$ 18.350  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Lifemd Inc   16.48 $ 163.363  Millions$ 9.915  Millions
Longeveron Inc   16.43 $ 1.187  Millions$ 0.072  Millions
Bioage Labs Inc   15.82 $ 10.355  Millions$ 0.655  Millions
Vaxart Inc   15.09 $ 243.064  Millions$ 16.108  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Voyager Therapeutics Inc   14.71 $ 34.459  Millions$ 2.343  Millions
Halozyme Therapeutics Inc   14.68 $ 1,663.738  Millions$ 113.332  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
Skinhealth Systems Inc   14.42 $ 289.224  Millions$ 20.051  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Talkspace Inc   14.09 $ 246.631  Millions$ 17.506  Millions
Lifestance Health Group Inc   14.07 $ 1,584.834  Millions$ 112.665  Millions
10x Genomics Inc   13.90 $ 616.566  Millions$ 44.342  Millions
Amneal Pharmaceuticals Inc   13.90 $ 3,117.474  Millions$ 224.342  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Corcept Therapeutics Inc  13.54 $ 830.813  Millions$ 61.352  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Nrc Health  12.72 $ 139.996  Millions$ 11.004  Millions
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions

Date modified: 2026-09-08T01:08:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.